Logotipo Dedalus   Logotipo ABCD
Identificação       Preferências   Catálogos   Fale Conosco   Encerrar Sessão  
Buscas   Resultados   Buscas Anteriores   Meus Docs.   Histórico   Vocabulário   Ajuda
  Adicionar Reg. Meus Docs.  |  Localizar  |  Salvar / E-mail  

Registro Completo

Escolher formato: Padrão Ficha Formato Reduzido Nomes MARC Campos MARC
No. Registro   002315048
Entrada Principal   LinkLira, Fabio (*)
Título   LinkNeuropeptides, metabolic disorder and inflammation in colon cancer patients : contributing to the cachexia syndrome.
Imprenta   Milão : Society on Sarcopenia, Cachexia and Wasting Disorders, 2011.
Descrição   p. 3-11.
Idioma   Inglês
Assunto   LinkPERDA DE PESO
Autor Secundário   LinkSilvério, R. (*)
  LinkOyama, L. (*)
  LinkNascimento, C. O. (*)
  LinkBatista, M. (*)
  LinkLaviano, A. (*)
  LinkRossi-Fanelli, F. (*)
  LinkAlcântara, P. (*)
  LinkOtoch, J. (*)
  LinkSeelaender, Marilia Cerqueira Leite
Autor Secundário   LinkCachexia Conference (6. 2012 Milão)
Fonte   LinkIn: Journal of Cachexia, Sarcopenia and Muscle, v. 2, n. 4, p. 209-261, 2011
Localiz.Eletrônica    "Clicar" sobre o ícone para acessar o Currículo Lattes de Marilia Cerqueira Leite Seelaender 
Resumo/Outros   Background and aims: Cancer cachexia, a devastating wasting syndrome, affects around 50% of all cancer patients and up to 80% of those with the advanced form of the disease. Inflammation plays a pivotal role in cachexia affecting the control of central energy balance, tissue metabolism and function, and modulation of appetite. This study aimed to examine plasma lipid profile, neuropeptides, and inflammatory marker levels in cancer patients with and without cachexia. Methods: Forty-five subjects (control n=15, tumour-bearing patients without cachexia n=15, and tumour-bearing cachectic patients n=15). Samples were obtained from male and female patients, 18–100 years with gastrointestinal tumour, who underwent surgery at University Hospital (University of São Paulo). Approximately 10 mL of blood were collected in the surgical procedure within the venous access procedure of anaesthesia. The plasma lipid profile (Triglycerides, HDL-cholesterol, total cholesterol, NEFA), glucose, insulin, HOMA-IR, PAI-1, endotoxin, MSH, MCH and NPY levels were determined (Kits ELISA and colorimetric methods).
  Results: Total cholesterol levels were increased in tumour-bearing (without and with cachexia) patients (p<0.05). In addition, NEFA and PAI-1 levels were increased in cachectic patients only (p<0.05). In contrast, all neuropeptides assessed (MCH, MCH, and NPY) were decreased in cachectic tumour-bearing patients, as compared with the control group (p<0.05). Conclusion: These results indicate that cachectic cancer patients exhibit alterations in metabolism, inflammation and modified neurohormonal control of food intake, favouring the aggravation of the syndrome.

Escolher formato: Padrão Ficha Formato Reduzido Nomes MARC Campos MARC

Encerrar Sessão - Preferências - Fale Conosco - Ajuda - Ex Libris
Buscas - Resultados - Buscas Anteriores - Catálogos